SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-227040
Filing Date
2023-09-01
Accepted
2023-09-01 09:25:57
Documents
15
Period of Report
2023-09-01
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d525571d8k.htm   iXBRL 8-K 29020
2 EX-99.1 d525571dex991.htm EX-99.1 29711
7 GRAPHIC g525571sp1a.jpg GRAPHIC 4701
  Complete submission text file 0001193125-23-227040.txt   228461

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20230901.xsd EX-101.SCH 3290
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20230901_def.xml EX-101.DEF 13060
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20230901_lab.xml EX-101.LAB 21662
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20230901_pre.xml EX-101.PRE 13767
9 EXTRACTED XBRL INSTANCE DOCUMENT d525571d8k_htm.xml XML 5294
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 231230844
SIC: 2836 Biological Products, (No Diagnostic Substances)